Drug used for treatment of methicillin resistant staphylococcus aureus is:
**Question:** Drug used for treatment of methicillin resistant staphylococcus aureus is:
A. Vancomycin
B. Penicillin
C. Ciprofloxacin
D. Amoxicillin
**Correct Answer:** A. Vancomycin
**Core Concept:**
Methicillin-resistant Staphylococcus aureus (MRSA) is a type of bacteria that has developed resistance to beta-lactam antibiotics, including penicillin. This resistance is due to the production of beta-lactamase enzymes, which break down the beta-lactam ring in penicillin, rendering it ineffective.
**Why the Correct Answer is Right:**
Vancomycin is a glycopeptide antibiotic that works by inhibiting the synthesis of bacterial cell wall peptidoglycan, leading to cell wall fragility and ultimately cell death. Since MRSA has developed resistance to beta-lactams, vancomycin is often the drug of choice for treating MRSA infections.
**Why Each Wrong Option is Incorrect:**
A. Penicillin: As mentioned earlier, MRSA has developed resistance to penicillin due to beta-lactamase production, making penicillin an ineffective treatment option.
B. Ciprofloxacin: Ciprofloxacin is a fluoroquinolone antibiotic, which primarily targets bacterial DNA gyrase and topoisomerase IV enzymes. MRSA does not exhibit cross-resistance to fluoroquinolones, making them a suitable alternative to vancomycin for some MRSA infections. However, vancomycin is often preferred due to its safety profile and fewer side effects compared to fluoroquinolones.
C. Amoxicillin: Amoxicillin is a beta-lactam antibiotic similar to penicillin, which is ineffective against MRSA due to beta-lactamase production.
**Clinical Pearl:**
When treating MRSA infections, it is essential to consider the patient's clinical presentation, severity, and potential co-existing conditions. In severe cases or when vancomycin is contraindicated, alternative antibiotics like daptomycin, linezolid, or teicoplanin can be used, but vancomycin remains a first-line choice for most MRSA infections.
**Explanation:**
Vancomycin is a suitable alternative to penicillin due to its safety profile and fewer side effects compared to fluoroquinolones. However, it is essential to differentiate between MRSA and methicillin-sensitive Staphylococcus aureus (MSSA) infections, as MSSA can be treated with beta-lactam antibiotics like penicillin and amoxicillin.